| 654: A THIRD DOSE OF SARS-COV-2 VACCINE YIELDS HIGH ANTIBODY LEVELS COMPARED TO TWO DOSE VACCINATION SCHEDULE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE J Quan, C Ma, R Panaccione, J Kanji, C Charlton, G Tipples, N Sharifi, ... Gastroenterology 162 (7), S-160, 2022 | | 2022 |
| A Role for the Vacuolating Cytotoxin, VacA, in Colonization and Helicobacter pylori–Induced Metaplasia in the Stomach JA Winter, DP Letley, KW Cook, JL Rhead, AAM Zaitoun, RJM Ingram, ... The Journal of infectious diseases 210 (6), 954-963, 2014 | 101 | 2014 |
| A173 INNOVATIVE CARE FOR INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: USE OF BEDSIDE INTESTINAL ULTRASOUND TO OPTIMIZE MANAGEMENT KL Novak, C Ma, H Kheirkhahrahimabadi, j heatherington, R Ingram, ... Journal of the Canadian Association of Gastroenterology 4 (Supplement_1 …, 2021 | | 2021 |
| A192 EFFICACY OF USTEKINUMAB IN SMALL BOWEL STRICTURES OF FIBROSTENOTIC CROHN'S DISEASE AS ASSESSED BY INTESTINAL ULTRASOUND J St-Pierre, R Rosentreter, A Kiraly, J Hart Szostakiwskyj, K Novak, ... Journal of the Canadian Association of Gastroenterology 6 (Supplement_1), 37-38, 2023 | | 2023 |
| A220 MORTALITY IN PATIENTS WITH ULCERATIVE COLITIS UNDERGOING COLECTOMY (2016-2020) NS Ahmed, S Krawchuk, k buhler, I Stukalin, J Besney, A Shaheen, ... Journal of the Canadian Association of Gastroenterology 7 (Supplement_1 …, 2024 | | 2024 |
| A234 DOES FECAL CALPROTECTIN CORRELATE WITH INFLAMMATION ON ULTRASOUND IN CROHN’S DISEASE STRICTURES? V Gulhati, RE Rosentreter, M Motamedi, A Macci, R Ingram, GG Kaplan, ... Journal of the Canadian Association of Gastroenterology 7 (Supplement_1 …, 2024 | | 2024 |
| A258 ULTRASOUND ASSESSMENT OF CROHN’S DISEASE PATIENTS FOLLOWING RISANKIZUMAB INITIATION; BASELINE, 3 AND 6 MONTH FOLLOW UP RE Rosentreter, R Ingram, C Ma, M Chan, T Shukla, S Devlin, GG Kaplan, ... Journal of the Canadian Association of Gastroenterology 7 (Supplement_1 …, 2024 | | 2024 |
| A54 DIETARY COMPONENTS ARE ASSOCIATED WITH FECAL CALPROTECTIN IN ULCERATIVE COLITIS E Chiu, L Taylor, R Ingram, R Panaccione, S Ghosh, H Ramay, K McCoy, ... Journal of the Canadian Association of Gastroenterology 5 (Supplement_1), 62-63, 2022 | | 2022 |
| Acetarsol is an effective and safe option in the management of refractory ulcerative colitis K Argyriou, RJM Ingram, R Blatt, P Wilson, S Samuel, C Hawkey, ... JOURNAL OF CROHNS & COLITIS 12, S340-S340, 2018 | | 2018 |
| Adverse events and serological responses after SARS-coV-2 vaccination in individuals with inflammatory bowel disease A Markovinović, J Quan, M Herauf, L Hracs, JW Windsor, N Sharifi, ... Official journal of the American College of Gastroenterology| ACG 118 (9 …, 2023 | 3 | 2023 |
| Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study GG Kaplan, C Ma, C Charlton, JN Kanji, G Tipples, N Sharifi, M Herauf, ... Gut 71 (6), 1229-1231, 2022 | 12 | 2022 |
| Assessment of Crohn's disease patients following risankizumab initiation using intestinal ultrasound: A prospective study R Rosentreter, R Ingram, C Ma, M Chan, T Shukla, S Devlin, G Kaplan, ... JOURNAL OF CROHNS & COLITIS 18, I1385-I1385, 2024 | | 2024 |
| Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization J St-Pierre, M Delisle, H Kheirkhahrahimabadi, TM Goodsall, RV Bryant, ... Crohn's & Colitis 360 5 (4), otad050, 2023 | 7 | 2023 |
| Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease J Quan, A Markovinović, L Hracs, C Ma, R Panaccione, GG Kaplan, ... The Lancet Gastroenterology & Hepatology 8 (12), 1074-1075, 2023 | | 2023 |
| CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa KW Cook, DP Letley, RJM Ingram, E Staples, H Skjoldmose, JC Atherton, ... Gut 63 (10), 1550-1559, 2014 | 163 | 2014 |
| Correlation between fecal calprotectin and inflammation on ultrasound in fibrostenotic Crohn's Disease V Gulhati, R Rosentreter, M Motamedi, A Macci, R Ingram, G Kaplan, ... JOURNAL OF CROHNS & COLITIS 18, I948-I948, 2024 | | 2024 |
| DOP14 Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised … M Iacucci, RJM Ingram, A Bazarova, R Cannatelli, N Labarile, ... Journal of Crohn's and Colitis 16 (Supplement_1), i063-i064, 2022 | 2 | 2022 |
| Duodenal ulcer promoting gene: effects on the pathophysiology of Helicobacter pylori infection and the host immune response RJM Ingram University of Nottingham, 2017 | 2* | 2017 |
| EXPERIENCES OF USING VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN THE EAST MIDLANDS JR White, S Din, R Ingram, S Foley, M Alam, R Robinson, R Francis, ... GUT 68, A102-A102, 2019 | | 2019 |
| Experiences of using vedolizumab in the treatment of inflammatory bowel disease in the East Midlands UK–a retrospective observational study JR White, S Din, RJM Ingram, S Foley, MA Alam, R Robinson, R Francis, ... Scandinavian Journal of Gastroenterology 55 (8), 907-916, 2020 | 8 | 2020 |
